Your browser doesn't support javascript.
loading
Safety and efficacy of rivastigmine in children with Down syndrome: A double blind placebo controlled trial.
Spiridigliozzi, Gail A; Hart, Sarah J; Heller, James H; Schneider, Heather E; Baker, Jane Ann; Weadon, Cathleen; Capone, George T; Kishnani, Priya S.
Afiliación
  • Spiridigliozzi GA; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina.
  • Hart SJ; Department of Pediatrics, Duke University Medical Center, Durham, North Carolina.
  • Heller JH; Formerly of Department of Surgery, Duke University Medical Center, Durham, North Carolina.
  • Schneider HE; Department of Neuropsychology, Kennedy Krieger Institute, Baltimore, Maryland.
  • Baker JA; Department of Pediatrics, Duke University Medical Center, Durham, North Carolina.
  • Weadon C; Down Syndrome Clinic and Research Center, Kennedy Krieger Institute, Baltimore, Maryland.
  • Capone GT; Down Syndrome Clinic and Research Center, Kennedy Krieger Institute, Baltimore, Maryland.
  • Kishnani PS; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Am J Med Genet A ; 170(6): 1545-55, 2016 06.
Article en En | MEDLINE | ID: mdl-27061338

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Down / Rivastigmina Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: Am J Med Genet A Asunto de la revista: GENETICA MEDICA Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Down / Rivastigmina Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: Am J Med Genet A Asunto de la revista: GENETICA MEDICA Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos